HCmed Innovations summarizes the development process of drug-nebulizer combination products, describing a roadmap from early development to commercialization.

This study aimed to evaluate two in-vitro test methods when assessing delivered dose for a breath-actuated mesh nebulizer, which only relies on a breathing simulator and the new method that incorporates a mixing inlet.

In this study, delivery of IFN-β-1b was assessed with two mesh nebulizers, a continuous output mode device and a breath-actuated nebulizer.

New technologies and regulatory requirements are calling upon companies to utilise different methods as they try to create the best product possible.

The novel breath actuated mesh nebuliser AdheResp generated a high delivered dose and good fine particle fraction data compared to a similar continuous-output nebulizer.

Biologics are increasingly being investigated for delivery with inhalation therapy, which has initiated more in-depth discussions about the implications of formulation development and their pairing with inhaled devices for more efficient outcomes.

In this article, HCmed Innovations presents data supporting the efficient delivery of a suspension formulation with mesh nebulizers.

This study investigated the performance of current available nebulizing technologies when nebulizing MESNA, considering adult and child breathing patterns, specifically for child delivery

Innovative breathing technologies have helped bring solutions to patients worldwide. One of these is smart breath-actuated nebulisers that can improve adherence by monitoring safe and effective use.